RetinalGenix Technologies (RTGN) Selling, General & Administrative (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.96 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -207.22 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 349.70 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.12 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 351.80 Mn |
| 10 | RetinalGenix Technologies | - | - | - | 262,149.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 262,149.00 |
| Dec 31, 2025 | 305,871.00 |
| Sep 30, 2025 | 270,153.00 |
| Jun 30, 2025 | 383,729.00 |
| Mar 31, 2025 | 341,203.00 |
| Dec 31, 2024 | 392,109.00 |
| Sep 30, 2024 | 244,098.00 |
| Jun 30, 2024 | 368,738.00 |
| Mar 31, 2024 | 328,985.00 |
| Dec 31, 2023 | 408,273.00 |
| Sep 30, 2023 | 167,046.00 |
| Jun 30, 2023 | 120,097.00 |
| Mar 31, 2023 | 203,242.00 |
| Dec 31, 2022 | 277,678.00 |
| Sep 30, 2022 | 201,148.00 |
| Jun 30, 2022 | 167,385.00 |
| Mar 31, 2022 | 161,195.00 |
| Dec 31, 2021 | 171,004.00 |
| Sep 30, 2021 | 293,893.00 |
| Jun 30, 2021 | 288,582.00 |
| Mar 31, 2021 | 367,470.00 |